NNNN
Anbio Biotechnology Ltd
NASDAQ · Biotechnology
$25.65
+1.59 (+6.61%)
Performance
1D
—
1W
+4.01%
1M
-28.13%
3M
+10.89%
6M
-47.18%
1Y
+344.54%
YTD
-12.99%
Open$24.00
Previous Close$24.06
Day High$26.00
Day Low$23.05
52W High$55.65
52W Low$5.18
Volume31.9K
Avg Volume111.6K
Market Cap3.69B
P/E Ratio618.28
EPS$0.04
SectorBiotechnology
Volume Analysis
0.29x average volume
Technical Indicators
SMA 50
$30.34
Below
SMA 200
$29.31
Below
RSI (14)
42.2
Neutral
Trend
Golden Cross
Bullish
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 8.27M | 6.74M | 1.91B |
| Net Income | 2.40M | 1.76M | -342,978,964 |
| Profit Margin | 29.0% | 27.5% | -18.0% |
| EBITDA | 2.04M | 1.58M | -481,091,076 |
| Free Cash Flow | — | — | -336,718,909 |
| Rev Growth | +22.7% | +22.7% | +20.7% |
| Debt/Equity | — | — | 0.38 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |